Development of Group B Streptococcal vaccine
NeoStrep is funded by the European Commission FP7 Programme HEALTH
WORK PACKAGE 2
WP2 will perform tasks necessary for delivering a vaccine product ready for clinical trials.
Transfer current laboratory scale manufacturing process to a contract manufacturer (CMO) for manufacturing of a vaccine product and associated documentation in preparation for clinical trials with the vaccine.
The specific objectives are: